Improving Wound Care
NPL is leading a £1.2 million project to improve the management of non-healing wounds in the NHS by translating novel technology from the laboratory into clinical practice.
scaffold that provides an architecture for
tissue regeneration.
Non-healing wounds cause pain, loss of sleep, reduced mobility and social isolation to patients, but also carry a significant financial burden. An estimated 340,000 people in the UK suffer from these wounds at a cost of £4,750 per patient, which is roughly 3% of national healthcare expenditure.
The new wound management and diagnostic technology (RegeniTherix™) has the potential to improve healing times and cut costs. NPL's role is to develop and validate 'multiplex' biomarker assays that allow the status of wounds to be monitored and so guide treatment.
The project is funded by the National Institute for Health Research's 'Invention for Innovation' (i4i) Programme and is a partnership with three SMEs (Neotherix, SensaPharm, and Complement Genomics Ltd) and the Leeds Teaching Hospitals Trust.
View a poster about the RegeniTherix™ technology
More on NPL's work in Biotechnology
For more information, please contact Alex Knight or James Hendry